US Patent Issued to NATIONAL CANCER CENTER, NATIONAL INSTITUTE FOR KOREAN MEDICINE DEVELOPMENT on May 26 for "Composition for preventing or treating lung cancer, comprising a compound isolated from Cephalotaxus extract as an active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,331, issued on May 26, was assigned to NATIONAL CANCER CENTER (Goyang-si, South Korea) and NATIONAL INSTITUTE FOR KOREAN MEDICINE DEVELOPMENT (Gyeongsan-si, South Korea).

"Composition for preventing or treating lung cancer, comprising a compound isolated from Cephalotaxus extract as an active ingredient" was invented by Kyung Sil Yoon (Goyang-si, South Korea), Yong Nyun Kim (Seoul, South Korea), Jae Gal Shim (Seoul, South Korea), Dong Hoon Shin (Seoul, South Korea), Hyo Jung Kim (Daegu, South Korea), Myoung Lae Cho (Gyeongsan-si, South Korea) and Soo Hyun Kim (Daegu, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure re...